naproxen has been researched along with aceclofenac in 10 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (aceclofenac) | Trials (aceclofenac) | Recent Studies (post-2010) (aceclofenac) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 336 | 60 | 168 |
| Protein | Taxonomy | naproxen (IC50) | aceclofenac (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 5.927 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carrasco, E; Felipe, A; Grau, M; Guasch, J; Juliá, S; Montero, JL | 2 |
| Bowdler, J; Frerick, H; Kornasoff, D; Montull, E | 1 |
| Clements, S; Cox, M; Harrall, RL; Hazleman, BL; Riley, GP | 1 |
| Fortea, J; Lamarca, R; Letzel, H; Mégard, Y; Raber, A | 1 |
| Kang, M; Kim, B; Kim, MG; Moon, SJ; Shin, N | 1 |
1 review(s) available for naproxen and aceclofenac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for naproxen and aceclofenac
| Article | Year |
|---|---|
Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Diclofenac; Double-Blind Method; Drug Administration Schedule; Edema; Erythema; Female; Humans; Knee Joint; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Range of Motion, Articular; Treatment Outcome | 1997 |
The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Naproxen; Pain Measurement; Self Administration; Treatment Outcome | 2006 |
Pharmacokinetic Interactions Between Tegoprazan and Naproxen, Aceclofenac, and Celecoxib in Healthy Korean Male Subjects.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Benzene Derivatives; Celecoxib; Cross-Over Studies; Diclofenac; Humans; Imidazoles; Male; Naproxen; Republic of Korea; Tablets | 2022 |
6 other study(ies) available for naproxen and aceclofenac
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzoquinones; Capillary Permeability; Carrageenan; Diclofenac; Edema; Female; Granuloma; Indomethacin; Male; Mice; Naproxen; Pain; Phenylbutazone; Pleurisy; Rats; Rats, Inbred Strains; Silver Nitrate; Stomach Ulcer; Synovitis | 1991 |
The pharmacological profile of aceclofenac, a new nonsteroidal antiinflammatory and analgesic drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dogs; Female; Indomethacin; Male; Mice; Naproxen; Phenylbutazone; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Culture Techniques; Diclofenac; Female; Glycosaminoglycans; Humans; Indomethacin; Male; Middle Aged; Naproxen; Tendons; Wound Healing | 2001 |